...
首页> 外文期刊>International journal of molecular medicine >HPV16/18 E5, a promising candidate for cervical cancer vaccines, affects SCPs, cell proliferation and cell cycle, and forms a potential network with E6 and E7
【24h】

HPV16/18 E5, a promising candidate for cervical cancer vaccines, affects SCPs, cell proliferation and cell cycle, and forms a potential network with E6 and E7

机译:HPV16 / 18 E5是宫颈癌疫苗的有希望的候选物,可影响SCP,细胞增殖和细胞周期,并与E6和E7形成潜在的网络

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The spindle checkpoint proteins (SCPs), which sense the existence of misaligned sister chromatids during mitosis and meiosis, are essential for cell proliferation and differentiation. Therefore, the role of SCPs in carcinogenesis is gaining increased attention. In this study, we analysed the expression of Bub1 and Mad2 in clinical samples by immunohistochemistry (IHC) during the development of cervical cancer (CC), and we explored the interaction of Bub1/Mad2 with different proteins through immunoprecipitation (IP). Furthermore, we analysed the characteristics of four different cell models of human papillomavirus (HPV)16/18 E5. We demonstrated that with the progression of CC, the expression of Bub1 and Mad2 was gradually reduced under the influence of HPVE5. Overexpression of HPV16/18 E5 significantly increased cell proliferation, as well as the percentage of cells in the S?phase. In addition, the levels of p21, Bub1 and Mad2 were markedly decreased in E5-expressing cells. Therefore, HPV16/18 E5 plays a critical role in carcinogenesis and is a potential therapeutic target in CC treatment.
机译:纺锤体检查点蛋白(SCPs)在细胞有丝分裂和减数分裂中感觉到未对准的姐妹染色单体的存在,对细胞增殖和分化至关重要。因此,SCP在致癌作用中的作用越来越受到关注。在这项研究中,我们通过免疫组化(IHC)分析了宫颈癌(CC)发生期间临床样品中Bub1和Mad2的表达,并通过免疫沉淀(IP)探索了Bub1 / Mad2与不同蛋白质的相互作用。此外,我们分析了人类乳头瘤病毒(HPV)16/18 E5的四种不同细胞模型的特征。我们证明,随着CC的发展,Bub1和Mad2的表达在HPVE5的影响下逐渐降低。 HPV16 / 18 E5的过表达显着增加了细胞增殖以及S?期细胞的百分比。另外,在表达E5的细胞中p21,Bub1和Mad2的水平显着降低。因此,HPV16 / 18 E5在致癌作用中起关键作用,并且是CC治疗中的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号